[{"OtherAccruedLiabilitiesCurrent_0_Q1_USD":4000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":166000.0,"ProceedsFromSaleOfRestrictedInvestments_1_Q1_USD":21968000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_1_Q1_USD":0.0,"LiabilitiesCurrent_0_Q1_USD":4031000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":102614000.0,"Liabilities_0_Q1_USD":29358000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":1460000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-5383000.0,"RestructuringCharges_1_Q1_USD":57000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":26416000.0,"GainLossOnSaleOfPropertyPlantEquipment_1_Q1_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":0.0,"GainLossOnSaleOfEquityInvestments_1_Q1_USD":0.0,"AdditionalPaidInCapital_0_Q1_USD":56803000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":12315000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-47977000.0,"LongTermInvestments_0_Q1_USD":3215000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":8612000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":26416000.0,"PaymentsForProceedsFromInvestments_1_Q1_USD":24369000.0,"InterestExpense_1_Q1_USD":1041000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":8176000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":10416000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":2657000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":2887000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":408000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":166000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":12315000.0,"OperatingIncomeLoss_1_Q1_USD":-13147000.0,"OperatingExpenses_1_Q1_USD":14638000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":3553000.0,"Revenues_1_Q1_USD":1491000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-986932000.0,"RestructuringReserve_0_Q1_USD":19000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.25,"StockholdersEquity_0_Q1_USD":73256000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":67683586.0,"NonoperatingIncomeExpense_1_Q1_USD":-714000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":1445000.0,"DividendsPreferredStockCash_1_Q1_USD":2978000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-10000.0,"DebtSecuritiesAvailableForSaleUnrealizedGainLoss_1_Q1_USD":251000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":-16839000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":360000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":500000.0,"Depreciation_1_Q1_USD":500000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":2000.0,"AccountsReceivableNetCurrent_0_Q1_USD":1072000.0,"AccountsPayableTradeCurrent_0_Q1_USD":519000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":439000.0,"InvestmentIncomeInterest_1_Q1_USD":345000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":-18000.0,"Assets_0_Q1_USD":102614000.0,"ForeignCurrencyTransactionGainLossUnrealized_1_Q1_USD":-10000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":3565000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q1_USD":3065000.0,"LossContingencyEstimateOfPossibleLoss_0_Q1_USD":400000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q1_USD":112000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":30400000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":252000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":0.0,"OtherAssetsNoncurrent_0_Q1_USD":233000.0,"IncreaseDecreaseInOtherOperatingLiabilities_1_Q1_USD":-131000.0,"NetIncomeLoss_1_Q1_USD":-13861000.0,"AssetsCurrent_0_Q1_USD":88333000.0,"IncomeLossFromEquityMethodInvestments_1_Q1_USD":0.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-15453000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-2401000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":12481000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-13610000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-132000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-3602000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":2370000.0,"CommonStockValue_0_Q1_USD":911099000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-13861000.0,"CommonStockSharesOutstanding_0_Q1_shares":56850172.0,"CommonStockNoParValue_0_Q1_USD":null,"PreferredStockSharesOutstanding_0_Q1_shares":1164000.0,"PreferredStockSharesIssued_0_Q1_shares":1164000.0,"PreferredStockSharesAuthorized_0_Q1_shares":1164000.0,"PreferredStockNoParValue_0_Q1_USD":null,"PreferredStockIncludingAdditionalPaidInCapitalNetOfDiscount_0_Q1_USD":140263000.0,"PreferredStockDividendsAndOtherAdjustments_1_Q1_USD":2978000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":0.0,"CommonStockSharesIssued_0_Q1_shares":56850172.0,"ShareBasedCompensation_1_Q1_USD":1445000.0,"Ticker":"ABUS","CIK":"1447028","name":"ARBUTUS BIOPHARMA CORP","OfficialName":"Arbutus Biopharma Corporation Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"388180699.0","Country":"Canada","Sector":"nan","Industry":"nan","Market":"NASDAQ","SP500":"nan","filed":"20200511"}]